SMAD7 and colitis: Consistently, in the T-cell transfer colitis model, treatment of colitic mice with AhR activators attenuates the mucosal inflammation induced by wild-type T cells but does not influence colitis induced by Smad7 Tg T cells (Monteleone et al., 2016).